Spots Global Cancer Trial Database for Tumoral Circulating Cells and Colorectal Cancer Progression

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Tumoral Circulating Cells and Colorectal Cancer Progression

Official Title: Characterization of Tumoral Circulating Cells According to Stage of Progression of Colorectal Cancers

Study ID: NCT03256084

Conditions

Colorectal Cancer

Interventions

Blood and tumor samples

Study Description

Brief Summary: Prospective research of circulating tumor cells as markers of progression risk in colorectal cancer.

Detailed Description: This study aims at allowing a better understanding of which circulating tumor cells (CTC) have the higher risk of metastasis of in the overall population of CTC. Prospective monocenter open-label study. In the frame of the management of the disease, blood samples will be collected at different times of treatment, regarding disease status (localized of stage II/III, metastatic non resectable, metastatic potentially resectable). Tissue samples will be collected for patients scheduled for surgery.